Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Debopam Samanta

Concepts (319)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
25
2024
187
12.890
Why?
Seizures
21
2024
209
4.980
Why?
Spasms, Infantile
9
2024
30
4.150
Why?
Anticonvulsants
12
2023
128
3.910
Why?
Cannabidiol
5
2022
35
3.760
Why?
Status Epilepticus
6
2021
41
3.600
Why?
Tuberous Sclerosis
6
2022
39
3.550
Why?
Mutation
16
2023
1420
3.220
Why?
Electroencephalography
17
2022
358
2.450
Why?
Epilepsies, Myoclonic
4
2020
11
2.420
Why?
Intellectual Disability
5
2023
153
2.350
Why?
Humans
101
2024
54478
2.330
Why?
Hemiplegia
3
2021
11
2.200
Why?
Brain
9
2019
1428
2.110
Why?
Child
35
2024
7480
1.930
Why?
Developmental Disabilities
5
2019
128
1.830
Why?
Epilepsy, Absence
3
2019
11
1.790
Why?
Magnetic Resonance Imaging
15
2019
1610
1.680
Why?
Neuroaxonal Dystrophies
2
2022
9
1.530
Why?
Nervous System Malformations
3
2020
17
1.510
Why?
Tumor Suppressor Proteins
3
2023
140
1.510
Why?
Folate Receptor 1
2
2022
24
1.490
Why?
Epilepsies, Partial
2
2022
13
1.400
Why?
Infant, Newborn, Diseases
2
2020
66
1.380
Why?
Ketamine
2
2020
65
1.370
Why?
Neurocutaneous Syndromes
2
2019
6
1.260
Why?
Infant
17
2023
3907
1.230
Why?
Cadherins
2
2019
72
1.220
Why?
Child, Preschool
18
2024
4221
1.170
Why?
Cerebral Arteries
2
2019
39
1.150
Why?
Epilepsy, Generalized
2
2023
11
1.130
Why?
Sirolimus
2
2017
64
1.110
Why?
Angiofibroma
2
2015
6
1.080
Why?
Facial Neoplasms
2
2015
23
1.060
Why?
Nerve Tissue Proteins
2
2018
203
1.040
Why?
Valproic Acid
2
2022
34
1.030
Why?
Stroke
3
2019
530
0.950
Why?
Pregnanolone
2
2023
7
0.950
Why?
Male
32
2021
27632
0.890
Why?
Landau-Kleffner Syndrome
1
2022
3
0.890
Why?
Female
28
2023
28502
0.880
Why?
Aphasia
1
2022
29
0.850
Why?
Quality Improvement
2
2022
244
0.830
Why?
Nervous System Diseases
2
2021
98
0.820
Why?
Chromosome Deletion
3
2019
146
0.810
Why?
Abnormalities, Multiple
3
2023
166
0.810
Why?
Treatment Outcome
9
2023
5587
0.790
Why?
Emergencies
1
2021
91
0.770
Why?
Pharmaceutical Preparations
1
2021
82
0.770
Why?
Angelman Syndrome
1
2020
2
0.760
Why?
Transition to Adult Care
1
2020
16
0.760
Why?
Bone Diseases, Developmental
2
2023
13
0.740
Why?
Immunoglobulins, Intravenous
1
2021
57
0.740
Why?
Tooth Abnormalities
2
2023
11
0.740
Why?
Fenfluramine
1
2020
8
0.730
Why?
Oligonucleotides, Antisense
1
2020
31
0.730
Why?
Phenobarbital
1
2020
18
0.720
Why?
Dioxolanes
1
2020
13
0.720
Why?
Flunarizine
1
2019
1
0.720
Why?
Behavioral Symptoms
1
2019
5
0.720
Why?
Excitatory Amino Acid Antagonists
1
2020
57
0.710
Why?
Immunologic Factors
1
2021
127
0.710
Why?
Ocular Physiological Phenomena
1
2019
4
0.700
Why?
Tetrasomy
1
2019
2
0.700
Why?
Agenesis of Corpus Callosum
2
2018
9
0.700
Why?
Chromosomes, Human, Pair 5
1
2019
17
0.700
Why?
Sneddon Syndrome
1
2019
3
0.700
Why?
Livedo Reticularis
1
2019
5
0.690
Why?
Oral Ulcer
1
2019
3
0.690
Why?
Behcet Syndrome
1
2019
7
0.690
Why?
Calcium Channel Blockers
1
2019
71
0.690
Why?
Transposases
1
2019
10
0.680
Why?
Andersen Syndrome
1
2019
1
0.680
Why?
Genetic Therapy
1
2020
120
0.680
Why?
Receptors, GABA-B
1
2019
12
0.680
Why?
Vitiligo
1
2019
8
0.680
Why?
Hydrocephalus
1
2019
44
0.680
Why?
Spinal Cord Diseases
1
2019
40
0.670
Why?
Nephrotic Syndrome
2
2017
22
0.670
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.670
Why?
Leukoencephalopathies
1
2019
16
0.670
Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.670
Why?
Migraine Disorders
2
2020
46
0.670
Why?
Edema
1
2019
72
0.660
Why?
Electron Transport Complex IV
1
2018
29
0.660
Why?
Cannabinoid Receptor Agonists
1
2019
51
0.660
Why?
Cerebral Infarction
1
2018
40
0.660
Why?
Muscle Weakness
1
2019
47
0.660
Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.650
Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.650
Why?
Shab Potassium Channels
1
2018
2
0.650
Why?
Photic Stimulation
1
2018
63
0.650
Why?
Optic Atrophy
1
2018
19
0.650
Why?
Alopecia
1
2019
41
0.640
Why?
Physicians
1
2022
248
0.640
Why?
Brain Edema
1
2018
39
0.640
Why?
Parents
1
2021
348
0.640
Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.630
Why?
Myoclonus
1
2018
10
0.630
Why?
Artifacts
1
2018
59
0.620
Why?
Thrombocytopenia
1
2019
98
0.620
Why?
Mitochondrial Diseases
1
2018
50
0.620
Why?
Autoimmune Diseases
1
2019
114
0.620
Why?
Biomedical Research
1
2021
248
0.610
Why?
Neurodegenerative Diseases
1
2018
89
0.610
Why?
Practice Guidelines as Topic
1
2020
492
0.600
Why?
Osteochondrodysplasias
1
2017
14
0.590
Why?
Hearing Loss, Sensorineural
1
2018
81
0.590
Why?
Immunologic Deficiency Syndromes
1
2017
21
0.590
Why?
Arteriosclerosis
1
2017
61
0.580
Why?
Carotid Artery Diseases
1
2017
38
0.580
Why?
Phenotype
2
2021
798
0.570
Why?
Drug Discovery
1
2017
90
0.570
Why?
Health Knowledge, Attitudes, Practice
1
2021
535
0.570
Why?
Child Development
1
2018
205
0.570
Why?
Models, Biological
1
2020
809
0.560
Why?
Prenatal Exposure Delayed Effects
1
2018
190
0.560
Why?
Cafe-au-Lait Spots
1
2016
2
0.560
Why?
Erythema Infectiosum
1
2015
3
0.550
Why?
Migraine with Aura
1
2015
4
0.550
Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.550
Why?
Corpus Callosum
2
2023
27
0.550
Why?
Williams Syndrome
1
2016
29
0.550
Why?
Sinus Pericranii
1
2015
1
0.540
Why?
Adolescent
12
2023
6938
0.540
Why?
Parvovirus B19, Human
1
2015
17
0.540
Why?
Syndrome
6
2024
249
0.540
Why?
Toes
1
2015
17
0.540
Why?
SOS1 Protein
1
2015
2
0.540
Why?
Crying
1
2015
4
0.540
Why?
Electrodiagnosis
1
2015
14
0.540
Why?
Moyamoya Disease
1
2015
7
0.540
Why?
Iatrogenic Disease
1
2015
24
0.540
Why?
Pulmonary Embolism
1
2017
107
0.540
Why?
Hyperventilation
1
2015
8
0.540
Why?
Tuberculoma
1
2015
3
0.530
Why?
Epilepsy, Benign Neonatal
1
2015
3
0.530
Why?
Skin
1
2019
467
0.530
Why?
Infant, Newborn
5
2020
2933
0.530
Why?
Noonan Syndrome
1
2015
12
0.530
Why?
Neurologic Examination
1
2015
81
0.530
Why?
Encephalitis
1
2016
50
0.520
Why?
Mutism
1
2015
3
0.520
Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.520
Why?
Communication
3
2022
262
0.520
Why?
Ocular Motility Disorders
1
2015
21
0.520
Why?
TOR Serine-Threonine Kinases
1
2015
82
0.510
Why?
Repressor Proteins
2
2023
164
0.510
Why?
Trisomy
1
2014
36
0.510
Why?
Energy Drinks
1
2014
6
0.500
Why?
Diagnosis, Differential
7
2020
1155
0.490
Why?
KCNQ2 Potassium Channel
1
2014
18
0.490
Why?
Neurology
1
2015
44
0.490
Why?
Vasoconstriction
1
2014
60
0.490
Why?
Influenza, Human
1
2015
115
0.480
Why?
Benzodiazepines
1
2014
73
0.480
Why?
Osteomyelitis
1
2015
128
0.480
Why?
Membrane Proteins
1
2016
379
0.460
Why?
Sleep
1
2014
203
0.450
Why?
Enzyme Inhibitors
1
2015
448
0.440
Why?
Magnetic Resonance Angiography
3
2019
81
0.430
Why?
Immunosuppressive Agents
3
2019
247
0.410
Why?
Pediatrics
1
2015
329
0.390
Why?
Quality of Life
3
2022
933
0.380
Why?
Receptors, N-Methyl-D-Aspartate
2
2022
131
0.370
Why?
Diffusion Magnetic Resonance Imaging
3
2017
125
0.370
Why?
Caregivers
2
2021
233
0.340
Why?
Recurrence
3
2019
690
0.330
Why?
Echinocandins
1
2008
64
0.320
Why?
Mycoses
1
2008
165
0.300
Why?
Gastroesophageal Reflux
2
2019
51
0.290
Why?
Administration, Topical
2
2015
68
0.270
Why?
Antifungal Agents
1
2008
362
0.270
Why?
Retrospective Studies
6
2023
6512
0.250
Why?
Intralaminar Thalamic Nuclei
1
2024
14
0.240
Why?
Psychosurgery
1
2023
5
0.240
Why?
Deep Brain Stimulation
1
2024
50
0.230
Why?
Laser Therapy
1
2023
91
0.220
Why?
Speech Disorders
1
2022
18
0.220
Why?
Ethosuximide
1
2022
5
0.220
Why?
Clonazepam
1
2022
5
0.220
Why?
Electrodes, Implanted
1
2022
30
0.220
Why?
Stereotaxic Techniques
1
2022
37
0.220
Why?
Cluster Analysis
1
2023
258
0.210
Why?
Death, Sudden
1
2022
13
0.210
Why?
GTPase-Activating Proteins
1
2022
26
0.210
Why?
Concept Formation
1
2021
12
0.210
Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
5
0.200
Why?
Freedom
1
2021
3
0.200
Why?
Diazepam
1
2021
22
0.200
Why?
Folic Acid
1
2022
142
0.200
Why?
Drug Interactions
1
2022
226
0.200
Why?
Fibroma
1
2021
41
0.200
Why?
Adrenocorticotropic Hormone
2
2022
36
0.190
Why?
Dihydroergotamine
1
2020
4
0.190
Why?
Personal Satisfaction
1
2021
89
0.190
Why?
Brain Diseases
1
2021
86
0.190
Why?
Soft Tissue Neoplasms
1
2021
66
0.190
Why?
Risk Factors
2
2020
3916
0.190
Why?
Facies
2
2023
35
0.190
Why?
Perception
1
2021
137
0.180
Why?
Diet Therapy
1
2020
8
0.180
Why?
Genetic Diseases, Inborn
1
2020
24
0.180
Why?
Consensus
1
2021
163
0.180
Why?
Ubiquitin-Protein Ligases
1
2020
100
0.180
Why?
Transcription Factors
2
2023
632
0.180
Why?
Clinical Protocols
1
2020
120
0.180
Why?
Qualitative Research
1
2021
347
0.180
Why?
Anesthetics
1
2020
37
0.180
Why?
Treatment Failure
1
2020
138
0.180
Why?
Leukomalacia, Periventricular
1
2019
12
0.180
Why?
Matrix Attachment Region Binding Proteins
1
2020
33
0.180
Why?
Muscle Hypotonia
1
2019
22
0.180
Why?
Chromosomes, Human, Pair 7
1
2019
30
0.170
Why?
HLA-B51 Antigen
1
2019
2
0.170
Why?
Patient-Centered Care
1
2021
133
0.170
Why?
Learning
1
2021
170
0.170
Why?
Craniofacial Abnormalities
1
2019
28
0.170
Why?
Ventriculoperitoneal Shunt
1
2019
28
0.170
Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.170
Why?
Heart Septal Defects, Atrial
1
2019
47
0.170
Why?
Ventricular Premature Complexes
1
2019
7
0.170
Why?
Analgesics, Non-Narcotic
1
2020
142
0.170
Why?
Disease Management
1
2020
185
0.170
Why?
Microcephaly
1
2019
44
0.170
Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.170
Why?
Facial Nerve Diseases
1
2018
6
0.170
Why?
Randomized Controlled Trials as Topic
1
2022
594
0.170
Why?
Syncope
1
2019
30
0.160
Why?
Referral and Consultation
1
2021
304
0.160
Why?
Nocturnal Myoclonus Syndrome
1
2018
14
0.160
Why?
Cerebral Veins
1
2018
17
0.160
Why?
Facial Paralysis
1
2018
24
0.160
Why?
Anti-Arrhythmia Agents
1
2019
85
0.160
Why?
Deglutition Disorders
1
2019
79
0.160
Why?
Health Personnel
1
2021
257
0.160
Why?
Frameshift Mutation
1
2018
17
0.160
Why?
Video Recording
1
2018
93
0.160
Why?
Fatal Outcome
1
2019
223
0.160
Why?
Acute Disease
1
2019
413
0.160
Why?
Adult
4
2023
14229
0.160
Why?
Fibrinolytic Agents
1
2019
139
0.160
Why?
Fear
1
2018
89
0.150
Why?
Combined Modality Therapy
1
2020
687
0.150
Why?
Clinical Trials as Topic
1
2020
492
0.150
Why?
Anti-Inflammatory Agents
1
2019
177
0.150
Why?
India
1
2017
83
0.150
Why?
History, 21st Century
1
2017
65
0.150
Why?
Platelet Aggregation Inhibitors
1
2019
190
0.150
Why?
Cerebellum
1
2018
152
0.150
Why?
Methotrexate
1
2017
70
0.150
Why?
Neurotoxicity Syndromes
1
2017
52
0.150
Why?
History, 20th Century
1
2017
121
0.150
Why?
Anti-Infective Agents
1
2017
113
0.140
Why?
Pandemics
1
2021
589
0.140
Why?
Aldehyde Dehydrogenase
1
2016
28
0.140
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
108
0.140
Why?
Influenza B virus
1
2015
6
0.140
Why?
Hormones
1
2016
62
0.140
Why?
Delayed Diagnosis
1
2016
25
0.140
Why?
Chromosomes, Human, Pair 3
1
2015
21
0.140
Why?
North America
1
2015
72
0.130
Why?
Animals
3
2022
14779
0.130
Why?
Arkansas
1
2021
2171
0.130
Why?
Cerebral Angiography
1
2015
109
0.130
Why?
Chromosomes, Human, Pair 9
1
2014
20
0.130
Why?
Antibiotics, Antineoplastic
1
2015
82
0.130
Why?
Brain Waves
1
2014
23
0.130
Why?
Complementary Therapies
1
2015
31
0.130
Why?
Drug Resistance
1
2015
74
0.130
Why?
Antiemetics
1
2014
36
0.120
Why?
Headache
1
2014
79
0.120
Why?
Mutation, Missense
1
2014
108
0.120
Why?
Vomiting
1
2014
73
0.120
Why?
Glutamine
1
2015
171
0.120
Why?
Polymerase Chain Reaction
1
2015
534
0.120
Why?
Decision Making, Computer-Assisted
1
2013
5
0.110
Why?
Arginine
1
2015
192
0.110
Why?
Analgesics
1
2014
111
0.110
Why?
Vigabatrin
2
2022
3
0.110
Why?
Diagnostic Errors
1
2013
78
0.110
Why?
Evidence-Based Medicine
1
2013
278
0.100
Why?
Inflammation
1
2016
679
0.100
Why?
Pregnancy
1
2018
2579
0.100
Why?
Signal Transduction
1
2017
1734
0.090
Why?
Dysentery
1
2009
1
0.090
Why?
Trichuriasis
1
2009
1
0.090
Why?
Trichuris
1
2009
1
0.090
Why?
Anesthesia, Intravenous
1
2008
13
0.080
Why?
Eosinophils
1
2009
38
0.080
Why?
Antineoplastic Agents
1
2017
1296
0.080
Why?
Lipopeptides
1
2008
63
0.080
Why?
Amyloidosis
1
2009
84
0.080
Why?
Inflammatory Bowel Diseases
1
2009
60
0.080
Why?
Tuberculosis
1
2009
152
0.080
Why?
Candidiasis
1
2008
123
0.080
Why?
Aspergillosis
1
2008
132
0.080
Why?
Prospective Studies
2
2023
2534
0.070
Why?
Kidney Diseases
1
2009
292
0.070
Why?
Spasm
1
2024
10
0.060
Why?
Feedback
1
2024
58
0.060
Why?
Probability
1
2023
182
0.060
Why?
Neuroimaging
1
2023
90
0.060
Why?
Potassium Channels
1
2021
39
0.050
Why?
Administration, Intravenous
1
2020
74
0.050
Why?
Databases, Factual
1
2023
697
0.050
Why?
Sleep Stages
1
2020
49
0.050
Why?
Age of Onset
1
2020
115
0.040
Why?
Cognition
1
2022
359
0.040
Why?
Immunohistochemistry
1
2021
1090
0.040
Why?
Software
1
2013
291
0.020
Why?
Internet
1
2013
277
0.020
Why?
Young Adult
1
2020
4323
0.020
Why?
Antinematodal Agents
1
2009
3
0.020
Why?
Mebendazole
1
2009
3
0.020
Why?
Leukemoid Reaction
1
2009
7
0.020
Why?
Antitubercular Agents
1
2009
111
0.020
Why?
Colonoscopy
1
2009
106
0.020
Why?
Prognosis
1
2009
2060
0.010
Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description